Johnson and Johnson - 123RF

Johnson & Johnson on Wednesday forecast 2026 sales and profit ahead of Wall Street estimates, even when including a hit of “hundreds of millions of dollars” from ​the drug pricing deal it signed with the Trump administration earlier this month.